ProfileGDS4459 / ENSG00000196437
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 24% 17% 26% 24% 36% 31% 26% 30% 29% 27% 28% 33% 31% 15% 31% 53% 35% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.5324
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.317
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.2926
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.6424
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.8636
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.6831
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.3726
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.5130
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.4829
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.4327
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.5428
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.6633
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.6431
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.215
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.5531
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.4953
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.8935